SCHEDULE 13G: Vanguard Group Discloses 6.93% Passive Stake in Core Scientific Inc.

The Vanguard Group has reported a 6.93% beneficial ownership stake in Core Scientific Inc. as of December 31, 2024, indicating a passive investment position.

Summary

• The Vanguard Group filed a Schedule 13G, reporting its beneficial ownership in Core Scientific Inc.
• As of December 31, 2024, Vanguard beneficially owned an aggregate of 19,378,652 shares of Core Scientific Inc. common stock.
• This ownership represents 6.93% of the company's outstanding common stock.
• Vanguard holds sole dispositive power over 18,866,269 shares and shared dispositive power over 512,383 shares.
• Vanguard holds shared voting power over 291,000 shares and no sole voting power.
• The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 6

Explanation: The filing itself is neutral as it's a compliance document. However, the disclosure of a significant passive stake by a major institutional investor like Vanguard can be viewed as a positive signal of confidence in the company, hence a slightly positive score.

Positives

• The disclosure of a significant stake by The Vanguard Group, a major institutional investor, can be interpreted as a vote of confidence in Core Scientific Inc.
• The filing indicates a passive investment, suggesting a long-term holding strategy rather than an activist intent.

Negatives

• The document itself is an ownership disclosure and does not contain negative financial or operational information about Core Scientific Inc.

Risks

• The document does not detail specific risks related to Core Scientific Inc.'s operations or financial health, as it is solely an ownership disclosure by an investor.

Future Outlook

This Schedule 13G filing is a disclosure of current beneficial ownership and does not contain forward-looking statements or guidance regarding Core Scientific Inc.'s future performance or The Vanguard Group's future investment intentions beyond the passive nature of the stake.

Management Comments

• The document is a regulatory filing by an institutional investor and does not contain direct quotes or paraphrased statements from Core Scientific Inc.'s management. The Vanguard Group's representative, Ashley Grim, Head of Global Fund Administration, certified the accuracy of the filing.

Industry Context

This filing reflects a routine disclosure by a large asset manager, The Vanguard Group, regarding its passive investment in Core Scientific Inc., a company likely involved in the digital asset or data center industry. Such disclosures are common for institutional investors holding significant stakes in publicly traded companies, indicating their portfolio allocations rather than specific industry trends.

Comparison to Industry Standards

• This document is a beneficial ownership report and does not provide financial or operational results for Core Scientific Inc. that can be compared to industry standards or specific comparable companies/projects. It solely details The Vanguard Group's stake.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional holder's passive stake, which might be viewed positively as a vote of confidence.

Next Steps

• The document does not outline any specific future actions, events, or milestones for Core Scientific Inc. or The Vanguard Group beyond the routine regulatory filing requirements.

Key Dates

Keywords

Core Scientific Inc., Vanguard Group, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing, Investment Management